Abstract
Purpose. Genes are of increasing interest as pharmaceuticals, but current methods for long-term gene delivery are inadequate. Controlled release systems using biocompatible and/or biodegradable polymers offer many advantages over conventional gene delivery approaches. We have characterized systems for controlled delivery of DNA from implantable polymer matrices (EVAc: poly (ethylene-co-vinyl acetate)) and injectable microspheres (PLGA and PLA: poly (D, L-lactide-co-glycolide) copolymer and poly (L-lactide), respectively).
Methods. Herring sperm DNA and bacteria phage λ DNA were encapsulated as a model system. Released DNA concentration was determined by fluoroassays. Agarose electrophoresis was used to determine the dependence of release rate on DNA size. The Green Fluorescent Protein (GFP) gene was used to determine the integrity and functionality of released DNA.
Results. Both small and large DNA molecules (herring sperm DNA, 0.1−0.6 kb; GFP, 1.9 kb; λ DNA, 48.5 kb) were successfully encapsulated and released from EVAc matrices, and PLGA or PLA microspheres. The release from DNA-EVAc systems was diffusion-controlled. When co-encapsulated in the same matrix, the larger λ DNA was released more slowly than herring sperm; the rate of release scaled with the DNA diffusion coefficient in water. The chemical and biological integrity of released DNA was not changed.
Conclusions. These low cost, and adjustable, controlled DNA delivery systems, using FDA-approved biocompatible/biodegradable and implantable/injectable materials, could be useful for in vivo gene delivery, such as DNA vaccination and gene therapy.
Similar content being viewed by others
REFERENCES
J. A. Wolff, R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. Direct gene transfer into mouse muscle in vivo. Science 47:1465-1468 (1990).
J. J. Donnelly, J. B. Ulmer, J. W. Shiver, and M. A. Liu. DNA vaccines. Annu. Rev. Immunol. 15:617-648 (1997).
W. F. Anderson. Human gene therapy. Nature 392:25-30 (1998).
R. G. Crystal. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410 (1995).
S. K. Tripathy, H. B. Black, E. Goldwasser, and J. M. Leiden. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550 (1996).
A. R. Thierry, P. Rabinovich, B. Peng, L. C. Mahan, J. L. Bryant, and R. C. Gallo. Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA. Gene Ther. 4:226-237 (1997).
Y. Liu, D. Liggitt, W. Zhong, G. Tu, K. Gaensler, and R. Debs. Cationic liposome-mediated intravenous gene delivery. J Biol. Chem. 270:24864-24870 (1995).
N. Ishii, J. Fukushima, T. Kaneko, E. Okada, K. Tani, S. I. Tanaka, K. Hamajima, K. Q. Xin, S. Kawamoto, W. Koff, K. Nishioka, T. Yasuda, and K. Okuda. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 13:1421-1428 (1997).
P. Erbacher, S. Zou, T. Bettinger, A. M. Steffan, and J. S. Remy. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability [In Process Citation]. Pharm. Res. 15:1332-1339 (1998).
P. Erbacher, A. C. Roche, M. Monsigny, and P. Midoux. The reduction of the positive charges of polylysine by partial gluconoylation increases the transfection efficiency of polylysine/DNA complexes. Biochim. Biophys. Acta 1324:27-36 (1997).
J. E. Murphy, T. Uno, J. D. Hamer, F. E. Cohen, V. Dwarki, and R. N. Zuckermann. A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proc. Natl. Acad. Sci. U S A 95:1517-1522 (1998).
E. F. Fynan, R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U S A 90:11478-11482 (1993).
S. L. Hart, R. P. Harbottle, R. Cooper, A. Miller, R. Williamson, and C. Coutelle. Gene delivery and expression mediated by an integrin-binding peptide Gene Ther. 2:552-554 (1995).
S. Katayose, and K. Kataoka. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug. Chem. 8:702-707 (1997).
J. S. Kim, B. I. Kim, A. Maruyama, T. Akaike, and S. W. Kim. A new non-viral DNA delivery vector: the terplex system. J. Contr. Rel. 53:175-182 (1998).
M. J. Mahoney, and W. M. Saltzman. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J. Pharm. Sci. 85:1276-1281 (1996).
S. Cohen, T. Yoshioka, M. Lucarelli, L. Hwang, and R. Langer. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8:713-720 (1991).
W. M. Saltzman, and R. Langer. Transport rates of proteins in porous materials with known microgeometry. Biophys. J. 55:163-171 (1989).
R. Siegel, and R. Langer. Controlled Release of Polypeptides and Other Macromolecules. Pharm. Res.:2-10 (1984).
E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chickering, P. Chaturvedi, C. A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386:410-414 (1997).
Y. S. Jong, J. S. Jacob, K. P. Yip, G. Gardner, E. Seitelman, M. Whitney, S. Montgomery, and E. Mathiowitz. Controlled release of plasmid DNA. J. Contr. Rel. 47:123-134 (1997).
V. Labhasetwar, J. Bonadio, S. Goldstein, W. Chen, and R. J. Levy. A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. J. Pharm. Sci. 87:1347-1350 (1998).
D. Wang, D. R. Robinson, G. S. Kwon, and J. Samuel. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Contr. Rel. 57:9-18 (1999).
S. Ando, D. Putnam, D. W. Pack, and R. Langer. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J. Pharm. Sci. 88:126-130 (1999).
C. E. Beaty, and W. M. Saltzman. Controlled growth factor delivery induces differental neurite outgrowth in three-dimensional cell cultures. J. Contr. Rel. 24:15-23 (1993).
D. H. Jones, S. Corris, S. McDonald, J. C. Clegg, and G. H. Farrar. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 15:814-817 (1997).
C. E. Krewson, R. Dause, M. Mak, and W. M. Saltzman. Stabilization of nerve growth factor in controlled release polymers and in tissue. J. Biomater. Sci. Polym. Ed. 8:103-117 (1996).
R. Langer, and J. Folkman. Polymers for the sustained release of proteins and other macromolecules. Nature 263:797-800 (1976).
W. Dang, and W. M. Saltzman. Dextran retention in the rat brain following release from a polymer implant. Biotechnol. Prog. 8:527-532 (1992).
K. Soda, and A. Wada. Dynamic Light-Scattering Studies on Thermal Motions of Native DNAs In Solution. Biophys. Chem. 20:185-200 (1984).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luo, D., Woodrow-Mumford, K., Belcheva, N. et al. Controlled DNA Delivery Systems. Pharm Res 16, 1300–1308 (1999). https://doi.org/10.1023/A:1014870102295
Issue Date:
DOI: https://doi.org/10.1023/A:1014870102295